Skip to content

Clinical trials

Phase 2 Mood Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Phase: Phase 2 Country / region: United States Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20033
20043
20051
20072
20083
20091
20101
20112
20121
20131
20141
20161
20173
20192
20204
20212
20221
20231
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated5
Recruiting4
Withdrawn2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)13
Brigham and Women's Hospital2
Marinus Pharmaceuticals2
Novartis Pharmaceuticals2
Seaport Therapeutics2
University of North Carolina, Chapel Hill2
University of Texas Southwestern Medical Center2
VA Office of Research and Development2
Bayside Health1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders49
Major Depressive Disorder24
Depressive Disorder16
Bipolar Disorder15
Mental Disorders15
Anxiety Disorders6
Psychotic Disorders4
Depression, Postpartum3
Depressive Disorder, Treatment-Resistant3
Mania3

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.